6505--Pylarify(Piflufolastat F18 Injection) for DC VAMC
ID: 36C24524Q0900Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF245-NETWORK CONTRACT OFFICE 5 (36C245)LINTHICUM, MD, 21090, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/ea8bbc7025a447138bd415ac6164458a/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified sources to provide Pylarify (Piflufolastat F18 Injection) for the DC Veterans Affairs Medical Center (DC VAMC) in Washington, D.C. The procurement involves the delivery of this radiopharmaceutical to the Nuclear Medicine Section of the Radiology Service, with a base contract period of one year and four optional one-year extensions. This product is critical for diagnostic imaging and treatment in nuclear medicine, and the contractor must ensure compliance with various regulatory standards while providing online ordering capabilities and timely deliveries. Interested parties should submit their responses, including company information and capabilities, to Ryan Singletary at Ryan.Singletary@va.gov by September 16, 2024, at 3:00 PM EST.

    Point(s) of Contact
    RYAN SINGLETARYCONTRACTING OFFICER
    (202) 745-8000
    RYAN.SINGLETARY@VA.GOV
    Files
    Title
    Posted
    _rels/.rels
    [Content_Types].xml
    docProps/app.xml
    docProps/core.xml
    word/_rels/document.xml.rels
    word/document.xml
    word/fontTable.xml
    word/footer1.xml
    word/footer2.xml
    word/header1.xml
    word/header2.xml
    word/settings.xml
    word/styles.xml
    word/theme/theme1.xml
    word/webSettings.xml
    Lifecycle
    Title
    Type
    6505--Pylarify(Piflufolastat F18 Injection) for DC VAMC
    Currently viewing
    Special Notice
    Similar Opportunities
    6505--VA Northern California Health Care System VA Medical Center - Martinez Radiopharmaceuticals & Radiopharmaceutical Supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide radiopharmaceuticals and radiopharmaceutical supplies for the VA Northern California Health Care System, specifically for the VA Medical Center in Martinez. The procurement aims to ensure a reliable supply of essential radiopharmaceuticals for diagnostic and therapeutic procedures, with a focus on quality control and compliance with federal regulations. This contract spans five ordering periods from April 1, 2025, to March 31, 2030, with a guaranteed minimum award of $100 and a maximum aggregate order limit of $1,200,000. Interested parties can contact Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov for further details.
    6505--36C26024Q0755 PLUVICTO LU 177 / RADIOPHARMACEUTICALS Clarification that vendors submitting quotes must have current Federal Supply Schedule Contract to be considered responsible. Procurement method FAR Part 8.
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Lutetium Lu 177 PLUVICTO radiopharmaceuticals for the Portland VA Medical Center. Vendors must possess a current Federal Supply Schedule (FSS) contract to ensure their quotes are considered responsible, as outlined in the solicitation amendment. This procurement is crucial for treating metastatic castration-resistant prostate cancer, emphasizing the government's commitment to meeting the medical needs of veterans. Interested parties should submit their quotes by November 8, 2024, at 1:00 PM Pacific Time, and can direct inquiries to José Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.
    6515--Radiopharmaceuticals-Tc-99m Wilmington VA Medical Center
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a market survey to identify potential vendors capable of supplying Radiopharmaceuticals Tc-99m to the Wilmington VA Medical Center in Delaware. Vendors must demonstrate their ability to deliver these critical medical supplies within two hours and comply with stringent licensing and regulatory standards, including state and federal guidelines for radioactive materials. This procurement is vital for ensuring timely healthcare services for veterans, with the contract structured as an Indefinite Delivery Indefinite Quantity (IDIQ) agreement spanning one base year and four option years. Interested parties must submit their capability statements and relevant experience by November 7, 2024, to Christa Stine, Contract Specialist, at christa.stine@va.gov.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0001 for the procurement of Pegfilgrastim, aimed at ensuring a continuous supply for various entities including VA facilities, Consolidated Mail Order Pharmacies, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a responsible offeror capable of providing Pegfilgrastim with a unique National Drug Code (NDC) and adhering to strict labeling guidelines, prohibiting the affixing of new labels over existing ones. The estimated annual requirement is for 8,458 syringes across multiple variants, with the RFP expected to be released electronically around November 5, 2024, and responses due by November 19, 2024. Interested parties should monitor sam.gov for updates and direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--Notice of Intent to Award a Sole Source Procurement - Lu177 Therapy
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through Network Contracting Office 17, intends to award a sole source procurement to Advanced Accelerator Applications USA Inc. for the supply of LUTATHERA® (lutetium Lu 177 dotatate) and PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan). This procurement includes an order for 20 units of LUTATHERA® and 100 units of PLUVICTO™, based on Novartis's confirmation that Advanced Accelerator Applications is the sole manufacturer and authorized supplier for these critical medical supplies. The timely acquisition of these items is essential for patient care within the Veterans Health Administration. Interested parties may submit capability statements within seven days of this notice; otherwise, the order will proceed without further notice. For inquiries, contact Vance Farrell at vance.farrell@va.gov or call 210-694-6379.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Lamotrigine Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care facilities, including the Department of Defense and the Bureau of Prisons. The contract will cover an unrestricted procurement for multiple strengths and packaging sizes of Lamotrigine IR Tablets, with specific requirements for labeling and packaging to ensure compliance with safety standards. This procurement is critical for maintaining the availability of essential medications for veterans and other federal beneficiaries. Interested offerors should note that the solicitation is expected to be released on or about November 7, 2024, with a closing date of November 21, 2024; inquiries can be directed to Contract Specialist Ray Roldan at raymond.roldan@va.gov or by phone at 708-786-4930.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Calcitonin Gene-Related Peptides (CGRP) through its Pharmaceutical Prime Vendor (PPV) Program. This procurement aims to establish a contract that ensures a consistent supply of these pharmaceutical products while adhering to federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). The CGRP products are critical for various medical treatments within VA facilities, emphasizing the importance of quality control and reliable delivery. Interested offerors must submit their proposals by November 7, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6515--Inhaled Nitric Oxide Gas and Delivery System New Base Plus Four Option Year Contract
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide an Inhaled Nitric Oxide Gas and Delivery System for the Washington DC VA Medical Center. This procurement aims to support critical care patients, particularly those with pulmonary hypertension or other serious conditions, by ensuring precise delivery and monitoring of inhaled nitric oxide in parts-per-million (PPM). The contract will consist of a base year plus four optional years, with deliverables including the gas, calibration sources, and consumables, while also requiring connectivity to hospital systems and battery operation for power failure scenarios. Interested suppliers must submit their responses by November 11, 2024, at 11:00 AM EST, to Zachary Altner at Zachary.Altner@va.gov.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the supply of Norethindrone Acetate Tablets under Request for Proposal (RFP) 36E79724R0027. The procurement aims to establish contracts for the pharmaceutical product, with specific requirements regarding pricing for a base year and four option years, compliance with packaging standards, and adherence to the Drug Supply Chain Security Act (DSCSA) regulations. This medication is essential for various health treatments within the VA system, ensuring that veterans receive necessary pharmaceutical care. Interested contractors must submit their proposals by November 15, 2024, at 2:30 PM Central Standard Time, to the designated email addresses provided in the solicitation documents. For further inquiries, potential bidders can contact Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.